| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Natera is at the forefront of product and service development, particularly in advancing cancer screening and genetic testing technologies. Recent innovations, such as new blood-based screening tests and the expansion of noninvasive prenatal genetic tests, demonstrate significant progress in both cancer detection and prenatal healthcare solutions. By leveraging cutting-edge cell-free DNA technology, Natera is positioning itself as a leader in healthcare innovation, catering to emerging needs in diagnostics. These advancements, however, also come with challenges, including regulatory hurdles and the need for ongoing validation of new technologies. |
| The price action of Natera (NTRA) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 0.8 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.NTRA is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1, and the negative at -0.2 on 2025-10-31. The forces of Sentiment towards Fundamentals (3.3), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Valuation Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| NTRA | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-31 | 0%(0%) | 1 | 0.25% | 0.8 | 3.3 | -1 | |||||||
| 2025-10-30 | 0%(0%) | 1 | 0.25% | 0.7 | 2.8 | -1 | |||||||
| 2025-10-29 | 0%(0%) | 1 | 0.25% | 0.7 | 2.7 | -1 | |||||||
| 2025-10-28 | 0%(0%) | 1 | 0.25% | 0.7 | 2.7 | -1 | |||||||
| 2025-10-27 | 0%(0%) | 1 | 0.25% | 0.4 | 0.8 | -1 | |||||||
| 2025-10-26 | 0%(0%) | 1 | 0.25% | 0.7 | 2.7 | -1 | |||||||
| 2025-10-25 | 0%(0%) | 1 | 0.25% | 0.7 | 2.7 | -1 | |||||||
| 2025-10-24 | 0%(0%) | 1 | 0.25% | 0.7 | 2.7 | -1 | |||||||
| 2025-10-23 | 0%(0%) | 1 | 0.25% | 0.7 | 2.5 | -1 | |||||||
| 2025-10-22 | 0%(0%) | 1 | 0.25% | 0.6 | 2.1 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-31 17:10:11 With plans to launch the new test in 2025, there is a strong indication of Natera's commitment to future growth and expansion in the genetic testing sector. |
| 2025-10-31 17:10:11 Natera's unique LinkedSNP technology provides a competitive edge in the market, enhancing the efficacy and reliability of their genetic testing services. |
| 2025-10-31 17:10:11 The launch of the expanded Fetal Focus test indicates a growing trend towards single-gene testing within the prenatal market, aligning with increased awareness and demand for genetic health insights. |
| 2025-10-31 17:10:11 Natera, Inc.'s stock experienced a notable increase, reflecting positive investor sentiment and confidence in the company's progress and offerings. |
| 2025-10-31 17:10:11 The expansion of Natera's Fetal Focus test to include 20 genes demonstrates significant progress in the field of noninvasive prenatal testing, showcasing innovation in genetic testing technology. |